• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在维持质子泵抑制剂治疗期间,与糜烂性胃食管反流病相比,非糜烂性反流病伴有更严重的上消化道症状。

More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.

作者信息

Kusano Motoyasu, Hosaka Hiroko, Kawamura Osamu, Kawada Akiyo, Kuribayashi Shiko, Shimoyama Yasuyuki, Yasuoka Hidetoshi, Mizuide Masafumi, Tomizawa Taku, Sagawa Toshihiko, Sato Ken, Yamada Masanobu

机构信息

Department of Gastroenterology, Gunma University Hospital, Maebashi, Gunma, Japan,

出版信息

J Gastroenterol. 2015 Mar;50(3):298-304. doi: 10.1007/s00535-014-0972-9. Epub 2014 Jun 12.

DOI:10.1007/s00535-014-0972-9
PMID:24919745
Abstract

BACKGROUND

During maintenance proton pump inhibitor (PPI) therapy, patients with gastroesophageal reflux disease (GERD) sometimes complain of upper gastrointestinal symptoms.

AIM

To evaluate upper gastrointestinal symptoms in patients on maintenance PPI therapy for erosive GERD or non-erosive reflux disease (NERD) without endoscopic mucosal breaks by using a new questionnaire.

METHODS

At Gunma University Hospital over a 12-month period during 2011-2012, we enrolled 30 consecutive patients with erosive GERD and 46 patients with NERD. All patients had been on maintenance PPI therapy for more than 1 year. We used the modified frequency scale for the symptoms of GERD (mFSSG) questionnaire to assess upper gastrointestinal symptoms. We also asked patients about their satisfaction with maintenance therapy and whether they wished to change their current PPI.

RESULTS

The NERD patients had significantly higher symptom scores than the erosive GERD patients. There was no difference in the treatment satisfaction rate between patients with erosive GERD and NERD, but more patients with NERD wanted to change their PPI therapy. There was no difference in the mFSSG score between NERD patients who wished to change their current PPI therapy and those who were satisfied with it.

CONCLUSIONS

During maintenance PPI therapy, upper gastrointestinal symptoms were more severe in NERD patients than in patients with erosive GERD. NERD patients often wished to change their PPI therapy, but this was not dependent on the severity of their upper GI symptoms.

摘要

背景

在质子泵抑制剂(PPI)维持治疗期间,胃食管反流病(GERD)患者有时会抱怨有上消化道症状。

目的

使用一份新问卷评估接受PPI维持治疗的糜烂性GERD或无内镜下黏膜破损的非糜烂性反流病(NERD)患者的上消化道症状。

方法

在2011年至2012年的12个月期间,我们在群马大学医院连续纳入了30例糜烂性GERD患者和46例NERD患者。所有患者均接受PPI维持治疗超过1年。我们使用改良的GERD症状频率量表(mFSSG)问卷来评估上消化道症状。我们还询问了患者对维持治疗的满意度以及他们是否希望更换当前的PPI。

结果

NERD患者的症状评分显著高于糜烂性GERD患者。糜烂性GERD患者和NERD患者的治疗满意率没有差异,但更多的NERD患者希望更换他们的PPI治疗。希望更换当前PPI治疗的NERD患者和对其满意的患者之间的mFSSG评分没有差异。

结论

在PPI维持治疗期间,NERD患者的上消化道症状比糜烂性GERD患者更严重。NERD患者经常希望更换他们的PPI治疗,但这并不取决于他们上消化道症状的严重程度。

相似文献

1
More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.在维持质子泵抑制剂治疗期间,与糜烂性胃食管反流病相比,非糜烂性反流病伴有更严重的上消化道症状。
J Gastroenterol. 2015 Mar;50(3):298-304. doi: 10.1007/s00535-014-0972-9. Epub 2014 Jun 12.
2
Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.添加促动力药对质子泵抑制剂(PPI)抵抗的非糜烂性反流病(NERD)患者的疗效:GERD症状频率量表(FSSG)在治疗策略决策中的意义。
Intern Med. 2010;49(15):1469-76. doi: 10.2169/internalmedicine.49.3615. Epub 2010 Aug 2.
3
Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.对经验性质子泵抑制剂治疗无效的烧心和上腹痛患者的算法处理方法。
Dig Dis Sci. 2011 Oct;56(10):2871-8. doi: 10.1007/s10620-011-1708-9. Epub 2011 Apr 22.
4
[Gastroesophageal reflux disease and dyspepsia--drug therapy].[胃食管反流病与消化不良——药物治疗]
Praxis (Bern 1994). 2006 Aug 2;95(31-32):1179-83. doi: 10.1024/0369-8394.95.31.1179.
5
Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.接受质子泵抑制剂维持治疗的患者中与残留胃食管反流病症状相关的因素。
World J Gastroenterol. 2017 Mar 21;23(11):2060-2067. doi: 10.3748/wjg.v23.i11.2060.
6
Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.质子泵抑制剂(PPI)抵抗的胃食管反流病患者的预处理预测研究及 PPI 剂量递增挑战-TORNADO 研究:日本酸相关症状研究组的一项多中心前瞻性研究。
J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24.
7
Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease.沃克在反流性食管炎、非糜烂性食管炎及质子泵抑制剂抵抗的胃食管反流病初始及维持治疗中的疗效
Medicine (Baltimore). 2020 Mar;99(11):e19520. doi: 10.1097/MD.0000000000019520.
8
Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease.沃克对于质子泵抑制剂抵抗的非糜烂性反流病患者胃食管反流症状的疗效
Intern Med. 2018 Sep 1;57(17):2443-2450. doi: 10.2169/internalmedicine.0492-17. Epub 2018 Mar 30.
9
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?质子泵抑制剂反应者,经阻抗和 pH 监测未被确认为 GERD 患者:他们是谁?
Neurogastroenterol Motil. 2014 Jan;26(1):28-35. doi: 10.1111/nmo.12221. Epub 2013 Aug 29.
10
Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors.体重不足的胃食管反流病患者的症状和生活质量及质子泵抑制剂的治疗反应。
J Gastroenterol Hepatol. 2012 May;27(5):913-8. doi: 10.1111/j.1440-1746.2011.07042.x.

引用本文的文献

1
Increase of transient lower esophageal sphincter relaxation associated with cascade stomach.与瀑布状胃相关的一过性下食管括约肌松弛增加。
J Clin Biochem Nutr. 2017 May;60(3):211-215. doi: 10.3164/jcbn.16-53. Epub 2017 Apr 7.
2
Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects.在 11690 名韩国受试者中,饮食因素对反流性食管炎和非糜烂性反流病的影响不同。
J Gastroenterol. 2017 Jul;52(7):818-829. doi: 10.1007/s00535-016-1282-1. Epub 2016 Nov 15.
3
New endoscopic classification of cascade stomach, a risk factor for reflux esophagitis.

本文引用的文献

1
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study.一项针对质子泵抑制剂治疗无效的非糜烂性反流病患者的理气剂随机、安慰剂对照、双盲临床试验:G-PRIDE研究。
J Gastroenterol. 2014 Oct;49(10):1392-405. doi: 10.1007/s00535-013-0896-9. Epub 2014 Feb 18.
2
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn.微观食管炎将非糜烂性反流病患者与功能性烧心患者区分开来。
J Gastroenterol. 2013 Apr;48(4):473-82. doi: 10.1007/s00535-012-0672-2. Epub 2012 Sep 25.
3
新的级联胃内镜分类,反流性食管炎的危险因素。
J Gastroenterol. 2017 Feb;52(2):211-217. doi: 10.1007/s00535-016-1214-0. Epub 2016 Apr 27.
4
Esophageal Epithelial-Derived IL-33 Is Upregulated in Patients with Heartburn.烧心患者食管上皮来源的白细胞介素-33上调。
PLoS One. 2016 Apr 25;11(4):e0154234. doi: 10.1371/journal.pone.0154234. eCollection 2016.
Response to gastroesophageal reflux disease therapy: assessment at 4 weeks predicts response/non-response at 8 weeks.
胃食管反流病治疗的反应:4 周时的评估可预测 8 周时的反应/无反应。
Digestion. 2012;85(4):282-7. doi: 10.1159/000336715. Epub 2012 Apr 21.
4
Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease.改良的胃食管反流病症状频率量表的制定和评估,以区分功能性消化不良与非糜烂性反流病。
J Gastroenterol Hepatol. 2012 Jul;27(7):1187-91. doi: 10.1111/j.1440-1746.2012.07121.x.
5
PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.PPI 疗法在明确诊断的非糜烂性反流病和反流性食管炎中同样有效:一项荟萃分析。
Neurogastroenterol Motil. 2012 Aug;24(8):747-57, e350. doi: 10.1111/j.1365-2982.2012.01888.x. Epub 2012 Feb 6.
6
Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan.一项在日本开展的前瞻性、随机、多中心试验显示,和胃汤可改善 PPI 抵抗型 GERD 患者的症状。
J Gastroenterol. 2012 Mar;47(3):284-92. doi: 10.1007/s00535-011-0488-5. Epub 2011 Nov 15.
7
Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs-TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in Japan.质子泵抑制剂(PPI)抵抗的胃食管反流病患者的预处理预测研究及 PPI 剂量递增挑战-TORNADO 研究:日本酸相关症状研究组的一项多中心前瞻性研究。
J Gastroenterol. 2011 Nov;46(11):1273-83. doi: 10.1007/s00535-011-0446-2. Epub 2011 Aug 24.
8
Gastroesophageal reflux disease (GERD): a review of conventional and alternative treatments.胃食管反流病(GERD):传统与替代治疗方法综述
Altern Med Rev. 2011 Jun;16(2):116-33.
9
A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.一项比较新型钾离子竞争型酸阻滞剂 TAK-438 与兰索拉唑在动物体内抗分泌作用的研究。
J Pharmacol Exp Ther. 2011 Jun;337(3):797-804. doi: 10.1124/jpet.111.179556. Epub 2011 Mar 16.
10
Efficacy of the addition of prokinetics for proton pump inhibitor (PPI) resistant non-erosive reflux disease (NERD) patients: significance of frequency scale for the symptom of GERD (FSSG) on decision of treatment strategy.添加促动力药对质子泵抑制剂(PPI)抵抗的非糜烂性反流病(NERD)患者的疗效:GERD症状频率量表(FSSG)在治疗策略决策中的意义。
Intern Med. 2010;49(15):1469-76. doi: 10.2169/internalmedicine.49.3615. Epub 2010 Aug 2.